Copyright
©2014 Baishideng Publishing Group Inc.
World J Rheumatol. Nov 12, 2014; 4(3): 22-34
Published online Nov 12, 2014. doi: 10.5499/wjr.v4.i3.22
Published online Nov 12, 2014. doi: 10.5499/wjr.v4.i3.22
Supplement(n = studies) | Average dosage (maintenance dose) | Duration(wk) | Net leanmass change | Net strength change |
Cr (n = 18) | 19.4 g/d for 5.3 d (6.7 g/d) | 7.5 | +0.36%/wkb | +1.09%/wkb |
HMB (n = 9) | 3 g/d | 8 | +0.28%/wkb | +1.40%/wkb |
Chromium (n = 12) | 485 μg/d | 11.2 | +0.08%/wk | +0.25%/wk |
Androstenedione (n = 3) | 200 mg/d | 10.7 | +0.05%/wk | -0.06%/wk |
Protein (n = 4) | 1.15 g/kg per day | 6.3 | +0.12%/wk | -0.18%/wk |
DHEA (n = 2) | 125 mg/d | 10 | +0.12%/wk | +0.06%/wk |
- Citation: Wilkinson TJ, O’Brien TD, Lemmey AB. Oral creatine supplementation: A potential adjunct therapy for rheumatoid arthritis patients. World J Rheumatol 2014; 4(3): 22-34
- URL: https://www.wjgnet.com/2220-3214/full/v4/i3/22.htm
- DOI: https://dx.doi.org/10.5499/wjr.v4.i3.22